These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


338 related items for PubMed ID: 28852135

  • 1. Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia.
    Zhao H, Li H, Hao S, Chen J, Wu J, Song C, Zhang M, Qiao T, Li K.
    Sci Rep; 2017 Aug 29; 7(1):9840. PubMed ID: 28852135
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.
    Rötig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P.
    Nat Genet; 1997 Oct 29; 17(2):215-7. PubMed ID: 9326946
    [Abstract] [Full Text] [Related]

  • 4. Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly.
    Gakh O, Bedekovics T, Duncan SF, Smith DY, Berkholz DS, Isaya G.
    J Biol Chem; 2010 Dec 03; 285(49):38486-501. PubMed ID: 20889968
    [Abstract] [Full Text] [Related]

  • 5. Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia.
    Li K, Besse EK, Ha D, Kovtunovych G, Rouault TA.
    Hum Mol Genet; 2008 Aug 01; 17(15):2265-73. PubMed ID: 18424449
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Iron metabolism and mitochondrial abnormalities in Friedreich ataxia.
    Pandolfo M.
    Blood Cells Mol Dis; 2002 Aug 01; 29(3):536-47; discussion 548-52. PubMed ID: 12547248
    [Abstract] [Full Text] [Related]

  • 8. Missense mutations linked to friedreich ataxia have different but synergistic effects on mitochondrial frataxin isoforms.
    Li H, Gakh O, Smith DY, Ranatunga WK, Isaya G.
    J Biol Chem; 2013 Feb 08; 288(6):4116-27. PubMed ID: 23269675
    [Abstract] [Full Text] [Related]

  • 9. Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich's ataxia.
    Hackett PT, Jia X, Li L, Ward DM.
    J Biol Chem; 2022 Jun 08; 298(6):101982. PubMed ID: 35472330
    [Abstract] [Full Text] [Related]

  • 10. Frataxin and mitochondrial FeS cluster biogenesis.
    Stemmler TL, Lesuisse E, Pain D, Dancis A.
    J Biol Chem; 2010 Aug 27; 285(35):26737-26743. PubMed ID: 20522547
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Friedreich Ataxia: From the Eye of a Molecular Biologist.
    Muthuswamy S, Agarwal S.
    Neurologist; 2015 Sep 27; 20(3):51-5. PubMed ID: 26375377
    [Abstract] [Full Text] [Related]

  • 13. Targeting the gene in Friedreich ataxia.
    Hebert MD.
    Biochimie; 2008 Aug 27; 90(8):1131-9. PubMed ID: 18206656
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia.
    Vaubel RA, Isaya G.
    Mol Cell Neurosci; 2013 Jul 27; 55():50-61. PubMed ID: 22917739
    [Abstract] [Full Text] [Related]

  • 16. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
    Abeti R, Parkinson MH, Hargreaves IP, Angelova PR, Sandi C, Pook MA, Giunti P, Abramov AY.
    Cell Death Dis; 2016 May 26; 7(5):e2237. PubMed ID: 27228352
    [Abstract] [Full Text] [Related]

  • 17. Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.
    Medina-Carbonero M, Sanz-Alcázar A, Britti E, Delaspre F, Cabiscol E, Ros J, Tamarit J.
    Cell Mol Life Sci; 2022 Jan 17; 79(2):74. PubMed ID: 35038030
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic developments in Friedreich ataxia.
    Wilson RB.
    J Child Neurol; 2012 Sep 17; 27(9):1212-6. PubMed ID: 22791549
    [Abstract] [Full Text] [Related]

  • 19. The Regulation of the Disease-Causing Gene FXN.
    Dong YN, Mercado-Ayón E, Coulman J, Flatley L, Ngaba LV, Adeshina MW, Lynch DR.
    Cells; 2024 Jun 15; 13(12):. PubMed ID: 38920668
    [Abstract] [Full Text] [Related]

  • 20. Drp1-dependent peptide reverse mitochondrial fragmentation, a homeostatic response in Friedreich ataxia.
    Johnson J, Mercado-Ayón E, Clark E, Lynch D, Lin H.
    Pharmacol Res Perspect; 2021 May 15; 9(3):e00755. PubMed ID: 33951329
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.